메뉴 건너뛰기




Volumn 10, Issue , 2013, Pages

Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models

Author keywords

Alzheimer's disease; amyloid; British amyloidosis; transgenic mice; vaccination; sheet conformation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PROTEIN; PROTEIN PBRI; TAU PROTEIN; UNCLASSIFIED DRUG;

EID: 84889992513     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-150     Document Type: Article
Times cited : (40)

References (64)
  • 2
    • 84864232926 scopus 로고    scopus 로고
    • Disease modifying drugs targeting beta-amyloid
    • 10.1177/1533317512452034, 22815077
    • Ozudogru SN, Lippa CF. Disease modifying drugs targeting beta-amyloid. Am J Alzheimers Dis Other Demen 2012, 27:296-300. 10.1177/1533317512452034, 22815077.
    • (2012) Am J Alzheimers Dis Other Demen , vol.27 , pp. 296-300
    • Ozudogru, S.N.1    Lippa, C.F.2
  • 3
    • 84862315328 scopus 로고    scopus 로고
    • Active immunotherapy for Alzheimer's disease
    • 10.1016/S1474-4422(12)70136-9, 3560289, 22677257
    • Wisniewski T. Active immunotherapy for Alzheimer's disease. Lancet Neurol 2012, 11:571-572. 10.1016/S1474-4422(12)70136-9, 3560289, 22677257.
    • (2012) Lancet Neurol , vol.11 , pp. 571-572
    • Wisniewski, T.1
  • 4
    • 77951782384 scopus 로고    scopus 로고
    • Current therapeutic targets for the treatment of Alzheimer's disease
    • 10.1586/ern.10.29, 20420492
    • Grill JD, Cummings JL. Current therapeutic targets for the treatment of Alzheimer's disease. Expert Rev Neurother 2010, 10:711-728. 10.1586/ern.10.29, 20420492.
    • (2010) Expert Rev Neurother , vol.10 , pp. 711-728
    • Grill, J.D.1    Cummings, J.L.2
  • 5
    • 78650210590 scopus 로고    scopus 로고
    • Immunotherapy for Alzheimer's disease
    • 10.1111/j.1365-2796.2010.02315.x, 3074967, 21158978
    • Morgan D. Immunotherapy for Alzheimer's disease. J Intern Med 2011, 269:54-63. 10.1111/j.1365-2796.2010.02315.x, 3074967, 21158978.
    • (2011) J Intern Med , vol.269 , pp. 54-63
    • Morgan, D.1
  • 6
    • 84863337843 scopus 로고    scopus 로고
    • Alzheimer mechanisms and therapeutic strategies
    • 10.1016/j.cell.2012.02.040, 3319071, 22424230
    • Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222. 10.1016/j.cell.2012.02.040, 3319071, 22424230.
    • (2012) Cell , vol.148 , pp. 1204-1222
    • Huang, Y.1    Mucke, L.2
  • 8
    • 84876925888 scopus 로고    scopus 로고
    • The case for soluble Abeta oligomers as a drug target in Alzheimer's disease
    • 10.1016/j.tips.2013.03.002, 23582316
    • Hefti F, Goure WF, Jerecic J, Iverson KS, Walicke PA, Krafft GA. The case for soluble Abeta oligomers as a drug target in Alzheimer's disease. Trends Pharmacol Sci 2013, 34:261-266. 10.1016/j.tips.2013.03.002, 23582316.
    • (2013) Trends Pharmacol Sci , vol.34 , pp. 261-266
    • Hefti, F.1    Goure, W.F.2    Jerecic, J.3    Iverson, K.S.4    Walicke, P.A.5    Krafft, G.A.6
  • 10
    • 84874638938 scopus 로고    scopus 로고
    • Prions, prionoids and pathogenic proteins in Alzheimer disease
    • 10.4161/pri.23061, 3609051, 23208281
    • Ashe KH, Aguzzi A. Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion 2013, 7:55-59. 10.4161/pri.23061, 3609051, 23208281.
    • (2013) Prion , vol.7 , pp. 55-59
    • Ashe, K.H.1    Aguzzi, A.2
  • 11
    • 77950459664 scopus 로고    scopus 로고
    • Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models
    • 10.1007/s00429-009-0236-2, 3124148, 20012091
    • Wisniewski T, Boutajangout A. Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models. Brain Struct Funct 2010, 214:201-218. 10.1007/s00429-009-0236-2, 3124148, 20012091.
    • (2010) Brain Struct Funct , vol.214 , pp. 201-218
    • Wisniewski, T.1    Boutajangout, A.2
  • 12
    • 34447630226 scopus 로고    scopus 로고
    • Is vaccination against transmissible spongiform encephalopathies feasible?
    • Wisniewski T, Chabalgoity JA, Goni F. Is vaccination against transmissible spongiform encephalopathies feasible?. OIE Sci Tech Rev 2007, 26:243-251.
    • (2007) OIE Sci Tech Rev , vol.26 , pp. 243-251
    • Wisniewski, T.1    Chabalgoity, J.A.2    Goni, F.3
  • 13
    • 84872730067 scopus 로고    scopus 로고
    • Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis - but what lies beyond?
    • 10.1016/j.bcp.2012.11.014, 23178653
    • Mullane K, Williams M. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis - but what lies beyond?. Biochem Pharmacol 2013, 85:289-305. 10.1016/j.bcp.2012.11.014, 23178653.
    • (2013) Biochem Pharmacol , vol.85 , pp. 289-305
    • Mullane, K.1    Williams, M.2
  • 14
    • 0033600228 scopus 로고    scopus 로고
    • A stop-codon mutation in the BRI gene associated with familial British dementia
    • 10.1038/21637, 10391242
    • Vidal R, Frangione B, Rostagno A, Mead S, Revesz T, Plant G, Ghiso J. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999, 399:776-781. 10.1038/21637, 10391242.
    • (1999) Nature , vol.399 , pp. 776-781
    • Vidal, R.1    Frangione, B.2    Rostagno, A.3    Mead, S.4    Revesz, T.5    Plant, G.6    Ghiso, J.7
  • 16
    • 78149424228 scopus 로고    scopus 로고
    • Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease
    • 10.1371/journal.pone.0013391, 2954195, 20967130
    • Goni F, Prelli F, Ji Y, Scholtzova H, Yang J, Sun Y, Liang FX, Kascsak R, Kascsak R, Mehta P, Wisniewski T. Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease. PLoS ONE 2010, 5:e13391. 10.1371/journal.pone.0013391, 2954195, 20967130.
    • (2010) PLoS ONE , vol.5
    • Goni, F.1    Prelli, F.2    Ji, Y.3    Scholtzova, H.4    Yang, J.5    Sun, Y.6    Liang, F.X.7    Kascsak, R.8    Kascsak, R.9    Mehta, P.10    Wisniewski, T.11
  • 17
    • 79960359900 scopus 로고    scopus 로고
    • Vaccines: chasing the dream
    • 10.1038/475S18a, 21760578
    • Schnabel J. Vaccines: chasing the dream. Nature 2011, 475:S18-S19. 10.1038/475S18a, 21760578.
    • (2011) Nature , vol.475
    • Schnabel, J.1
  • 18
    • 2442594971 scopus 로고    scopus 로고
    • Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor
    • 10.1074/jbc.M312946200, 14985348
    • Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, Zlokovic BV, van Nostrand WE. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 2004, 279:20296-20306. 10.1074/jbc.M312946200, 14985348.
    • (2004) J Biol Chem , vol.279 , pp. 20296-20306
    • Davis, J.1    Xu, F.2    Deane, R.3    Romanov, G.4    Previti, M.L.5    Zeigler, K.6    Zlokovic, B.V.7    van Nostrand, W.E.8
  • 19
    • 0042697305 scopus 로고    scopus 로고
    • Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction
    • 10.1016/S0896-6273(03)00434-3, 12895417
    • Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421. 10.1016/S0896-6273(03)00434-3, 12895417.
    • (2003) Neuron , vol.39 , pp. 409-421
    • Oddo, S.1    Caccamo, A.2    Shepherd, J.D.3    Murphy, M.P.4    Golde, T.E.5    Kayed, R.6    Metherate, R.7    Mattson, M.P.8    Akbari, Y.9    LaFerla, F.M.10
  • 20
    • 85081459637 scopus 로고    scopus 로고
    • Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology
    • epub October 10
    • Liu S, Breitbart A, Sun Y, Mehta PD, Boutajangout A, Scholtzova H, Wisniewski T. Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology. J.Neurochem 2013, epub October 10.
    • (2013) J.Neurochem
    • Liu, S.1    Breitbart, A.2    Sun, Y.3    Mehta, P.D.4    Boutajangout, A.5    Scholtzova, H.6    Wisniewski, T.7
  • 21
    • 25144486849 scopus 로고    scopus 로고
    • Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein
    • 10.1016/S0002-9440(10)62993-8, 1603574, 16049335
    • Miao J, Xu F, Davis J, Otte-Holler I, Verbeek MM, van Nostrand WE. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 2005, 167:505-515. 10.1016/S0002-9440(10)62993-8, 1603574, 16049335.
    • (2005) Am J Pathol , vol.167 , pp. 505-515
    • Miao, J.1    Xu, F.2    Davis, J.3    Otte-Holler, I.4    Verbeek, M.M.5    van Nostrand, W.E.6
  • 22
    • 79955585471 scopus 로고    scopus 로고
    • Blocking the apolipoprotein E/amyloid β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice
    • 3132897, 21239853
    • Yang J, Ji Y, Mehta P, Bates KA, Sun Y, Wisniewski T. Blocking the apolipoprotein E/amyloid β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice. J Alzheimers Dis 2011, 24:269-285. 3132897, 21239853.
    • (2011) J Alzheimers Dis , vol.24 , pp. 269-285
    • Yang, J.1    Ji, Y.2    Mehta, P.3    Bates, K.A.4    Sun, Y.5    Wisniewski, T.6
  • 23
    • 33845484383 scopus 로고    scopus 로고
    • Blocking the apolipoprotein E/amyloid β interaction reduces the parenchymal and vascular amyloid-b deposition and prevents memory deficit in AD transgenic mice
    • 10.1073/pnas.0604011103, 1654132, 17116874
    • Sadowski M, Pankiewicz J, Scholtzova H, Mehta P, Prelli F, Quartermain D, Wisniewski T. Blocking the apolipoprotein E/amyloid β interaction reduces the parenchymal and vascular amyloid-b deposition and prevents memory deficit in AD transgenic mice. Proc Natl Acad Sci USA 2006, 103:18787-18792. 10.1073/pnas.0604011103, 1654132, 17116874.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 18787-18792
    • Sadowski, M.1    Pankiewicz, J.2    Scholtzova, H.3    Mehta, P.4    Prelli, F.5    Quartermain, D.6    Wisniewski, T.7
  • 24
    • 60849137841 scopus 로고    scopus 로고
    • Induction of Toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease related pathology
    • 10.1523/JNEUROSCI.5715-08.2009, 2699573, 19211891
    • Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T. Induction of Toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease related pathology. J Neurosci 2009, 29:1846-1854. 10.1523/JNEUROSCI.5715-08.2009, 2699573, 19211891.
    • (2009) J Neurosci , vol.29 , pp. 1846-1854
    • Scholtzova, H.1    Kascsak, R.J.2    Bates, K.A.3    Boutajangout, A.4    Kerr, D.J.5    Meeker, H.C.6    Mehta, P.D.7    Spinner, D.S.8    Wisniewski, T.9
  • 25
    • 0028593606 scopus 로고
    • Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
    • 10.1002/jnr.490390607, 7534834
    • Otvos L, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994, 39:669-673. 10.1002/jnr.490390607, 7534834.
    • (1994) J Neurosci Res , vol.39 , pp. 669-673
    • Otvos, L.1    Feiner, L.2    Lang, E.3    Szendrei, G.I.4    Goedert, M.5    Lee, V.M.6
  • 26
    • 0028946744 scopus 로고
    • Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
    • 10.1016/0304-3940(95)11484-E, 7624036
    • Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995, 189:167-169. 10.1016/0304-3940(95)11484-E, 7624036.
    • (1995) Neurosci Lett , vol.189 , pp. 167-169
    • Goedert, M.1    Jakes, R.2    Vanmechelen, E.3
  • 27
    • 0034521191 scopus 로고    scopus 로고
    • Lower cognitive performance of older football players possessing apolipoprotein E epsilon4
    • Kutner KC, Erlanger DM, Tsai J, Jordan B, Relkin NR. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. Neurosurgery 2000, 47:651-657.
    • (2000) Neurosurgery , vol.47 , pp. 651-657
    • Kutner, K.C.1    Erlanger, D.M.2    Tsai, J.3    Jordan, B.4    Relkin, N.R.5
  • 28
    • 24644438615 scopus 로고    scopus 로고
    • Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics
    • 10.1097/01.jnen.0000178444.33972.e0, 16141783
    • Morgan D, Gordon MN, Tan J, Wilcock D, Rojiani AM. Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol 2005, 64:743-753. 10.1097/01.jnen.0000178444.33972.e0, 16141783.
    • (2005) J Neuropathol Exp Neurol , vol.64 , pp. 743-753
    • Morgan, D.1    Gordon, M.N.2    Tan, J.3    Wilcock, D.4    Rojiani, A.M.5
  • 29
    • 57049085109 scopus 로고    scopus 로고
    • A NMDA receptor antagonist leads to behavioral improvement and amyloid reduction in Alzheimer's disease model transgenic mice shown by micro-magnetic resonance imaging
    • 10.1002/jnr.21713, 2723808, 18615702
    • Scholtzova H, Wadghiri YZ, Douadi M, Sigurdsson EM, Li Y, Quartermain D, Banerjee P, Wisniewski T. A NMDA receptor antagonist leads to behavioral improvement and amyloid reduction in Alzheimer's disease model transgenic mice shown by micro-magnetic resonance imaging. J Neurosci Res 2008, 86:2784-2791. 10.1002/jnr.21713, 2723808, 18615702.
    • (2008) J Neurosci Res , vol.86 , pp. 2784-2791
    • Scholtzova, H.1    Wadghiri, Y.Z.2    Douadi, M.3    Sigurdsson, E.M.4    Li, Y.5    Quartermain, D.6    Banerjee, P.7    Wisniewski, T.8
  • 30
    • 33644809258 scopus 로고    scopus 로고
    • Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease
    • 10.1002/mrm.20810, 16470593
    • Dhenain M, Delatour B, Walczak C, Volk A. Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease. Magn Reson Med 2006, 55:687-693. 10.1002/mrm.20810, 16470593.
    • (2006) Magn Reson Med , vol.55 , pp. 687-693
    • Dhenain, M.1    Delatour, B.2    Walczak, C.3    Volk, A.4
  • 31
    • 68349127365 scopus 로고    scopus 로고
    • Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice
    • 10.1016/j.neuroscience.2009.05.071, 19500657
    • Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience 2009, 163:55-72. 10.1016/j.neuroscience.2009.05.071, 19500657.
    • (2009) Neuroscience , vol.163 , pp. 55-72
    • Sanchez-Ramos, J.1    Song, S.2    Sava, V.3    Catlow, B.4    Lin, X.5    Mori, T.6    Cao, C.7    Arendash, G.W.8
  • 32
    • 77956057086 scopus 로고
    • Murine models of Alzheimer's disease and their use in developing immunotherapies
    • Wisniewski T, Sigurdsson EM. Murine models of Alzheimer's disease and their use in developing immunotherapies. Biochim Biophys Acta Mol Basis Dis 1802, 2010:847-859.
    • (1802) Biochim Biophys Acta Mol Basis Dis , vol.2010 , pp. 847-859
    • Wisniewski, T.1    Sigurdsson, E.M.2
  • 34
    • 75649133191 scopus 로고    scopus 로고
    • Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's disease
    • 10.1002/msj.20160, 3306842, 20101723
    • Lublin AL, Gandy S. Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's disease. Mt Sinai J Med 2010, 77:43-49. 10.1002/msj.20160, 3306842, 20101723.
    • (2010) Mt Sinai J Med , vol.77 , pp. 43-49
    • Lublin, A.L.1    Gandy, S.2
  • 35
    • 84876569513 scopus 로고    scopus 로고
    • Blocking the interaction between apolipoprotein E and Abeta reduces intraneuronal accumulation of Abeta and inhibits synaptic degeneration
    • 10.1016/j.ajpath.2013.01.034, 23499462
    • Kuszczyk MA, Sanchez S, Pankiewicz J, Kim J, Duszczyk M, Guridi M, Asuni AA, Sullivan PM, Holtzman DM, Sadowski MJ. Blocking the interaction between apolipoprotein E and Abeta reduces intraneuronal accumulation of Abeta and inhibits synaptic degeneration. Am J Pathol 2013, 182:1750-1768. 10.1016/j.ajpath.2013.01.034, 23499462.
    • (2013) Am J Pathol , vol.182 , pp. 1750-1768
    • Kuszczyk, M.A.1    Sanchez, S.2    Pankiewicz, J.3    Kim, J.4    Duszczyk, M.5    Guridi, M.6    Asuni, A.A.7    Sullivan, P.M.8    Holtzman, D.M.9    Sadowski, M.J.10
  • 36
    • 77954835300 scopus 로고    scopus 로고
    • High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
    • 10.1096/fj.09-150359, 20339023
    • Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M, Allsop D, Nakagawa M. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 2010, 24:2716-2726. 10.1096/fj.09-150359, 20339023.
    • (2010) FASEB J , vol.24 , pp. 2716-2726
    • Fukumoto, H.1    Tokuda, T.2    Kasai, T.3    Ishigami, N.4    Hidaka, H.5    Kondo, M.6    Allsop, D.7    Nakagawa, M.8
  • 39
    • 0142247606 scopus 로고    scopus 로고
    • PH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia
    • 10.1016/j.jmb.2003.09.001, 14583196
    • Srinivasan R, Jones EM, Liu K, Ghiso J, Marchant RE, Zagorski MG. pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia. J Mol Biol 2003, 333:1003-1023. 10.1016/j.jmb.2003.09.001, 14583196.
    • (2003) J Mol Biol , vol.333 , pp. 1003-1023
    • Srinivasan, R.1    Jones, E.M.2    Liu, K.3    Ghiso, J.4    Marchant, R.E.5    Zagorski, M.G.6
  • 42
    • 33750905657 scopus 로고    scopus 로고
    • Aβ derivative vaccination in alum adjuvant prevents amyloid deposition and does not cause brain microhemorrhages in Alzheimer's model mice
    • 10.1111/j.1460-9568.2006.05149.x, 1779823, 17100841
    • Asuni A, Boutajangout A, Scholtzova H, Knudsen E, Li Y, Quartermain D, Frangione B, Wisniewski T, Sigurdsson EM. Aβ derivative vaccination in alum adjuvant prevents amyloid deposition and does not cause brain microhemorrhages in Alzheimer's model mice. Eur J Neurosci 2006, 24:2530-2542. 10.1111/j.1460-9568.2006.05149.x, 1779823, 17100841.
    • (2006) Eur J Neurosci , vol.24 , pp. 2530-2542
    • Asuni, A.1    Boutajangout, A.2    Scholtzova, H.3    Knudsen, E.4    Li, Y.5    Quartermain, D.6    Frangione, B.7    Wisniewski, T.8    Sigurdsson, E.M.9
  • 43
    • 84862652390 scopus 로고    scopus 로고
    • Alum adjuvant: some of the tricks of the oldest adjuvant
    • 10.1099/jmm.0.038943-0, 22174375
    • Kool M, Fierens K, Lambrecht BN. Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol 2012, 61:927-934. 10.1099/jmm.0.038943-0, 22174375.
    • (2012) J Med Microbiol , vol.61 , pp. 927-934
    • Kool, M.1    Fierens, K.2    Lambrecht, B.N.3
  • 45
    • 58149385218 scopus 로고    scopus 로고
    • Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus
    • 10.1523/JNEUROSCI.2692-08.2008, 2673049, 19118188
    • Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, Arancio O. Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 2008, 28:14537-14545. 10.1523/JNEUROSCI.2692-08.2008, 2673049, 19118188.
    • (2008) J Neurosci , vol.28 , pp. 14537-14545
    • Puzzo, D.1    Privitera, L.2    Leznik, E.3    Fa, M.4    Staniszewski, A.5    Palmeri, A.6    Arancio, O.7
  • 48
    • 33749614555 scopus 로고    scopus 로고
    • Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein
    • 10.1001/archneur.63.10.1459, 17030663
    • Rosenmann H, Grigoriadis N, Karussis D, Boimel M, Touloumi O, Ovadia H, Abramsky O. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol 2006, 63:1459-1467. 10.1001/archneur.63.10.1459, 17030663.
    • (2006) Arch Neurol , vol.63 , pp. 1459-1467
    • Rosenmann, H.1    Grigoriadis, N.2    Karussis, D.3    Boimel, M.4    Touloumi, O.5    Ovadia, H.6    Abramsky, O.7
  • 50
    • 75649143681 scopus 로고    scopus 로고
    • Vaccination as a therapeutic approach for Alzheimer's disease
    • 10.1002/msj.20156, 3026780, 20101719
    • Wisniewski T, Boutajangout A. Vaccination as a therapeutic approach for Alzheimer's disease. Mt Sinai J Med 2010, 77:17-31. 10.1002/msj.20156, 3026780, 20101719.
    • (2010) Mt Sinai J Med , vol.77 , pp. 17-31
    • Wisniewski, T.1    Boutajangout, A.2
  • 53
    • 76749152337 scopus 로고    scopus 로고
    • Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases
    • 10.1159/000285518, 20173339
    • Jellinger KA. Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases. Neurodegener Dis 2010, 7:112-115. 10.1159/000285518, 20173339.
    • (2010) Neurodegener Dis , vol.7 , pp. 112-115
    • Jellinger, K.A.1
  • 54
    • 0036323445 scopus 로고    scopus 로고
    • Alzheimer disease and cerebrovascular pathology: an update
    • 10.1007/s007020200068, 12111471
    • Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002, 109:813-836. 10.1007/s007020200068, 12111471.
    • (2002) J Neural Transm , vol.109 , pp. 813-836
    • Jellinger, K.A.1
  • 55
    • 14844327519 scopus 로고    scopus 로고
    • Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease
    • Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci 2005, 229-230:37-41.
    • (2005) J Neurol Sci , vol.229-230 , pp. 37-41
    • Jellinger, K.A.1    Attems, J.2
  • 56
    • 0037062566 scopus 로고    scopus 로고
    • Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study
    • Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurol 2002, 58:1629-1634.
    • (2002) Neurol , vol.58 , pp. 1629-1634
    • Pfeifer, L.A.1    White, L.R.2    Ross, G.W.3    Petrovitch, H.4    Launer, L.J.5
  • 57
    • 34249780397 scopus 로고    scopus 로고
    • Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology
    • 10.1016/j.jns.2007.01.013, 17306303
    • Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci 2007, 257:49-55. 10.1016/j.jns.2007.01.013, 17306303.
    • (2007) J Neurol Sci , vol.257 , pp. 49-55
    • Attems, J.1    Quass, M.2    Jellinger, K.A.3    Lintner, F.4
  • 58
    • 7644219821 scopus 로고    scopus 로고
    • Amyloid angiopathy-related vascular cognitive impairment
    • 10.1161/01.STR.0000143224.36527.44, 15459438
    • Greenberg SM, Gurol ME, Rosand J, Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke 2004, 35:2616-2619. 10.1161/01.STR.0000143224.36527.44, 15459438.
    • (2004) Stroke , vol.35 , pp. 2616-2619
    • Greenberg, S.M.1    Gurol, M.E.2    Rosand, J.3    Smith, E.E.4
  • 59
    • 0742306942 scopus 로고    scopus 로고
    • Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - a pilot study
    • 10.1007/s00401-003-0796-9, 14655019
    • Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - a pilot study. Acta Neuropathol (Berl) 2004, 107:83-90. 10.1007/s00401-003-0796-9, 14655019.
    • (2004) Acta Neuropathol (Berl) , vol.107 , pp. 83-90
    • Attems, J.1    Jellinger, K.A.2
  • 62
    • 84878769054 scopus 로고    scopus 로고
    • Therapeutic strategies for tau mediated neurodegeneration
    • 10.1136/jnnp-2012-303144, 23085937
    • Yoshiyama Y, Lee VM, Trojanowski JQ. Therapeutic strategies for tau mediated neurodegeneration. J Neurol Neurosurg Psychiatry 2013, 84:784-795. 10.1136/jnnp-2012-303144, 23085937.
    • (2013) J Neurol Neurosurg Psychiatry , vol.84 , pp. 784-795
    • Yoshiyama, Y.1    Lee, V.M.2    Trojanowski, J.Q.3
  • 63
    • 84864497129 scopus 로고    scopus 로고
    • Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice
    • 10.1186/1750-1326-7-37, 3476970, 22866920
    • Rasool S, Albay R, Martinez-Coria H, Breydo L, Wu J, Milton S, Misra S, Tran A, Pensalfini A, LaFerla F, Kayed R, Glabe CG. Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice. Mol Neurodegener 2012, 7:37. 10.1186/1750-1326-7-37, 3476970, 22866920.
    • (2012) Mol Neurodegener , vol.7 , pp. 37
    • Rasool, S.1    Albay, R.2    Martinez-Coria, H.3    Breydo, L.4    Wu, J.5    Milton, S.6    Misra, S.7    Tran, A.8    Pensalfini, A.9    LaFerla, F.10    Kayed, R.11    Glabe, C.G.12
  • 64
    • 84888015869 scopus 로고    scopus 로고
    • Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice
    • 10.1007/s12035-013-8478-7, 23771815
    • Rasool S, Martinez-Coria H, Milton S, Glabe CG. Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice. Mol Neurobiol 2013, 48:931-940. 10.1007/s12035-013-8478-7, 23771815.
    • (2013) Mol Neurobiol , vol.48 , pp. 931-940
    • Rasool, S.1    Martinez-Coria, H.2    Milton, S.3    Glabe, C.G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.